ATE198983T1 - Verfahren zur inhibierung von aldh-i zur behandlung von alkoholabhaengigkeit oder- missbrauch - Google Patents

Verfahren zur inhibierung von aldh-i zur behandlung von alkoholabhaengigkeit oder- missbrauch

Info

Publication number
ATE198983T1
ATE198983T1 AT92915216T AT92915216T ATE198983T1 AT E198983 T1 ATE198983 T1 AT E198983T1 AT 92915216 T AT92915216 T AT 92915216T AT 92915216 T AT92915216 T AT 92915216T AT E198983 T1 ATE198983 T1 AT E198983T1
Authority
AT
Austria
Prior art keywords
alcohol
daidzin
pct
abuse
alcoholism
Prior art date
Application number
AT92915216T
Other languages
English (en)
Inventor
Bert L Vallee
Wing Ming Keung
Original Assignee
Endowment For Res In Human Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endowment For Res In Human Bio filed Critical Endowment For Res In Human Bio
Application granted granted Critical
Publication of ATE198983T1 publication Critical patent/ATE198983T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
AT92915216T 1991-07-01 1992-06-30 Verfahren zur inhibierung von aldh-i zur behandlung von alkoholabhaengigkeit oder- missbrauch ATE198983T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/723,404 US5204369A (en) 1991-07-01 1991-07-01 Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse
PCT/US1992/005598 WO1993000896A1 (en) 1991-07-01 1992-06-30 Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse

Publications (1)

Publication Number Publication Date
ATE198983T1 true ATE198983T1 (de) 2001-02-15

Family

ID=24906113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92915216T ATE198983T1 (de) 1991-07-01 1992-06-30 Verfahren zur inhibierung von aldh-i zur behandlung von alkoholabhaengigkeit oder- missbrauch

Country Status (9)

Country Link
US (3) US5204369A (de)
EP (1) EP0592583B1 (de)
JP (1) JP3170281B2 (de)
AT (1) ATE198983T1 (de)
AU (1) AU2308592A (de)
CA (1) CA2112703C (de)
DE (1) DE69231672T2 (de)
FI (1) FI935954A7 (de)
WO (1) WO1993000896A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204369A (en) * 1991-07-01 1993-04-20 The Endowment For Research In Human Biology Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse
KR930012028A (ko) * 1991-12-19 1993-07-20 박용성 생약제제
EP0656786B2 (de) * 1992-05-19 2014-04-23 Novogen Research Pty Ltd Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee
KR950007867A (ko) * 1993-09-22 1995-04-15 성우경 숙취증상의 예방 및 치료용 생약제 조성물
US5589182A (en) * 1993-12-06 1996-12-31 Tashiro; Renki Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression
US5523087A (en) * 1995-02-15 1996-06-04 Bio-Virus Research Incorporated Pharmaceutical compositions for the treatment of diabetic male sexual dysfunction
IT1274481B (it) * 1995-05-12 1997-07-17 Indena Spa Composizioni farmaceutiche per il trattamento della alcol-dipendenza
US5639785A (en) * 1995-06-07 1997-06-17 Global Pharma, Ltd. Methods for the treatment of baldness and gray hair using isoflavonoid derivatives
US5547671A (en) * 1995-09-20 1996-08-20 Duthinh; Phu Anti-intoxication composition
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5847108A (en) * 1996-03-21 1998-12-08 Fujicco Co., Ltd. Clathrate of isoflavone derivatives and edible composition comprising the same
US5783189A (en) * 1996-04-23 1998-07-21 Natural Pharmacia International, Inc. Method for treating alcohol dependence
JP2829387B2 (ja) * 1996-09-13 1998-11-25 農林水産省四国農業試験場長 脂肪細胞における脂肪分解促進用組成物
CA2279261A1 (en) * 1997-01-27 1998-07-30 Ling Ji The extract of pine needle and the use thereof
CZ298532B6 (cs) 1997-07-30 2007-10-31 Indena S. P. A. Sójový extrakt, zpusob jeho prípravy a farmaceutický prostredek, který jej obsahuje
US6221358B1 (en) * 1997-08-01 2001-04-24 Forestry Research Institute Method for lowering blood alcohol concentration by administering an extract of Rhus verniciflua
AU3899199A (en) * 1998-05-12 1999-11-29 Endowment for Research in Human Biology, Inc., The Methods and assays useful in the treatment of alcohol dependence or alcohol abuse
EP1645272A3 (de) * 1998-05-12 2008-11-05 The Endowment For Research In Human Biology, Inc. Daidzin-derivate zur Behandlung von Alkoholabhaengigkeit oder -Missbrauch
WO1999061028A1 (en) * 1998-05-27 1999-12-02 Gorbach Sherwood L Isoflavonoids for treatment and prevention of migraine headaches
US6063383A (en) * 1999-01-28 2000-05-16 Hsu; Wu-Ching Pharmaceutical suppository composites for fever and influenza and method of producing the composites
US6395299B1 (en) 1999-02-12 2002-05-28 Biostream, Inc. Matrices for drug delivery and methods for making and using the same
US6090780A (en) * 1999-04-07 2000-07-18 Chandon Prasad Histidyl-proline diketopiperazine and method of use
JP2002542187A (ja) * 1999-04-16 2002-12-10 アストラゼネカ・アクチエボラーグ エストロゲン−β受容体リガンド
WO2001091746A1 (en) * 2000-06-01 2001-12-06 The Mclean Hospital Corporation Method for treating alcohol intoxication and alcohol abuse
ES2375347T3 (es) * 2000-06-30 2012-02-29 Abdulla Badawy Métodos y composiciones para el tratamiento del alcoholismo y la dependencia del alcohol.
US20030100034A1 (en) * 2001-10-16 2003-05-29 Millennium Pharmaceuticals, Inc. 9136, a human aldehyde dehydrogenase family member and uses therefor
DE60231896D1 (de) 2001-11-05 2009-05-20 Krele Pharmaceuticals Llc Zusammensetzungen und verfahren zur erhöhung der compliance mit therapien unter verwendung von aldehyddehydrogenase-hemmern und zur behandlung von alkoholsmus
CN1671373A (zh) * 2002-06-27 2005-09-21 人类生物研究基金公司 用于抑制aldh的化合物
US20070202077A1 (en) * 2005-12-02 2007-08-30 Brodsky Robert A Use of High-Dose Oxazaphosphorine Drugs for Treating Immune Disorders
KR20090033417A (ko) 2006-07-27 2009-04-03 씨브이 쎄러퓨틱스, 인코포레이티드 중독의 치료에서의 ａｌｄｈ-2 저해제
US8158810B2 (en) * 2006-07-27 2012-04-17 Gilead Sciences, Inc. ALDH-2 inhibitors in the treatment of addiction
US20080207610A1 (en) * 2006-07-27 2008-08-28 Jeff Zablocki Aldh-2 inhibitors in the treatment of addiction
WO2008034071A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Method of identifying patients suitable for high-dose cyclophosphamide treatment
WO2008034074A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Cyclosphosphamide in combination with anti-idiotypic vaccines
WO2008034076A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Cyclophosphamide in combination with immune therapeutics
WO2008124532A1 (en) * 2007-04-05 2008-10-16 Cv Therapeutics, Inc. Quinazolinone derivatives as aldh-2 inhibitors
RU2010122970A (ru) * 2007-11-06 2011-12-20 Си Ви Терапьютикс, Инк. (Us) Ингибиторы aldh-2 при лечении психиатрических расстройств
WO2009067699A2 (en) * 2007-11-21 2009-05-28 Accentia Biopharmaceuticals, Inc. Methods for providing a system of care for an oxazaphosphorine drug regimen
US9026372B2 (en) * 2007-11-21 2015-05-05 Accentia Biopharmaceuticals, Inc. Methods for providing a system of care for a high-dose oxazaphosphorine drug regimen
AU2008348372A1 (en) * 2008-01-24 2009-07-30 Gilead Palo Alto, Inc. ALDH-2 inhibitors in the treatment of addiction
US20130165511A1 (en) 2010-09-01 2013-06-27 TONIX Pharmaceuticals Holding Corp Treatment for cocaine addiction
TWI567061B (zh) 2011-07-01 2017-01-21 吉李德科學股份有限公司 用於治療成癮之化合物
TWI468403B (zh) 2011-08-30 2015-01-11 Gilead Sciences Inc 用於治療成癮之ａｌｄｈ－２抑制劑
CN113521059A (zh) * 2021-09-06 2021-10-22 甘肃中医药大学 葛花小分子用于调节酒精依赖行为的新应用
US20230399299A1 (en) 2022-06-14 2023-12-14 Amygdala Neurosciences, Inc. Aldh-2 inhibitor compounds and methods of use
WO2023244574A1 (en) 2022-06-14 2023-12-21 Amygdala Neurosciences, Inc. Aldh-2 inhibitor compounds and methods of use
CN116942658A (zh) * 2023-06-21 2023-10-27 成都自然素生物科技有限公司 桑色素的新用途、及其自乳化给药系统和制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210882B (de) * 1961-07-14 1966-02-17 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Derivaten des 7-Oxychromons
US4131727A (en) * 1977-11-02 1978-12-26 President And Fellows Of Harvard College Method of purifying alcohol dehydrogenase and affinity resin therefor
ZA873745B (en) * 1986-06-04 1988-10-26 Daiichi Seiyaku Co Benzopyran derivatives
CN1007871B (zh) * 1987-08-24 1990-05-09 河南省医学科学研究所 葛根饮料的生产方法
US5002603A (en) * 1989-12-04 1991-03-26 Board Of Trustees Operating Michigan State University Method and compositions for stimulating vesicular-arbuscular mycorrhizal fungi
JPH089610B2 (ja) * 1990-04-06 1996-01-31 キノイン・ジョージセル・エーシュ・ヴェジェーセティ・テルメーケク・ジャーラ・エルテー 置換イソフラボン誘導体の改良された製造方法
US5204369A (en) * 1991-07-01 1993-04-20 The Endowment For Research In Human Biology Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse

Also Published As

Publication number Publication date
JPH07500316A (ja) 1995-01-12
FI935954L (fi) 1994-02-14
CA2112703A1 (en) 1993-01-02
EP0592583A1 (de) 1994-04-20
US5886028A (en) 1999-03-23
JP3170281B2 (ja) 2001-05-28
AU2308592A (en) 1993-02-11
DE69231672T2 (de) 2001-08-16
DE69231672D1 (de) 2001-03-08
US5624910A (en) 1997-04-29
WO1993000896A1 (en) 1993-01-21
FI935954A7 (fi) 1994-02-14
EP0592583B1 (de) 2001-01-31
FI935954A0 (fi) 1993-12-31
CA2112703C (en) 2007-04-24
US5204369A (en) 1993-04-20

Similar Documents

Publication Publication Date Title
ATE198983T1 (de) Verfahren zur inhibierung von aldh-i zur behandlung von alkoholabhaengigkeit oder- missbrauch
ATE271128T1 (de) Inhibitoren der il-6 aktivitaet
ATE474597T1 (de) Inhibition des migrations-inhibitions-faktors in der behandlung von krankheiten bei denen eine cytokin-vermittelte toxizität eine rolle spielt
ATE311184T1 (de) 1-benzyl-3-(substituiertes-hetaryl)-kondensiert n pyrazol-derivaten zur behandlung von erkrankungen des herz-kreislaufsystems und des zentralnervensystems
DE69515617D1 (de) Verwendung von antihelmintischen Zusammensetzungen zur Behandlung der durch Anoplocephala perfoliata verursachten Infektionen bei Pferden
DE69324671D1 (de) Verbesserte alpha-interferon-zusammensetzung und verfahren zu ihrer herstellung aus leukocyten des menschlichen peripheren blute
ATE136030T1 (de) Azaheterocyclylmethyl-chromane als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
DE69413167D1 (de) Peptid-Phosphinyloxymethyl-Ketonen als Inhibitoren von Interleukin-1 beta-konvertierenden Enzymen
ID22042A (id) Benzonaftiridin sebagai pengobatan cabang tenggorokan
DE69519937D1 (de) Polyamin-verbindungen zur behandlung von proliferativer erkrankungen
ATE312603T1 (de) Theanin enthaltende zusammensetzung zur unterdrückung von verhaltensstörungen der haustieren
GR3022765T3 (en) Arylamidoalkyl- and arylaminoalkyl-n-hydroxyurea compounds and -n-hydroxyformamide derivatives having lipoxygenase inhibitory activity
DE69840752D1 (de) Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen
DE69228814D1 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
ATE212845T1 (de) Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen
DE69941263D1 (de) Zusammensetzungen zur vorbeugung und behandlung der artheriosklerose und der restenose nach ptca
DE60015791D1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE104368T1 (de) Verfahren zur behandlung von karbidmetallverbundk¯rpern im bezug auf ihr gefuege und ihre zusammensetzung.
ATE180983T1 (de) Verfahren zum abbau von chinolonen und naphthyridonen
ATE128871T1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE146173T1 (de) Magnesiumsalz von 3-isopropyl-2,1,3- benzothiadiazin-4-on-2,2-dioxid, verfahren zu seiner herstellung und seine verwendung zur bekämpfung von unerwünschtem pflanzenwuchs
ATE225660T1 (de) Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenz
ATE123054T1 (de) N-acyl-phosphatidylethanolamin als oxidationsschutzmittel.
NO934911L (no) Fremgangsmåte for inhibering av AldH-I anvendelig ved behandling av alkoholavhengighet eller alkoholmisbruk